![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Optibiotix Health Plc | LSE:OPTI | London | Ordinary Share | GB00BP0RTP38 | ORD 2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 18.125 | 17.75 | 18.50 | 18.125 | 18.125 | 18.13 | 111,277 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Noncomml Resh Organizations | 457k | 2.59M | 0.0284 | 6.38 | 16.52M |
Date | Subject | Author | Discuss |
---|---|---|---|
09/10/2019 08:25 | The value largely hinges on Phase 3 results still and these are always very hard to predict. Today’s news is undoubtedly positive. But without knowing the Phase 3 outcome, any attempt at valuation remains a “finger in the air” job at this stage. | ![]() lord loads of lolly | |
09/10/2019 08:22 | Hami / Buywell ...yaaaaaaaaaaWn. Still here? Wipe the slime trail when leaving please.The Fantasy Island, pork pie telling team returns. | whitegold1 | |
09/10/2019 08:18 | 3p ... cant be right ... Goetz /SOH.s cunning plan Baldrick. | whitegold1 | |
09/10/2019 08:17 | GRAS In evaluating the safety of the intended use, the FDA considers only safety; benefits are not evaluated, although health claims may be considered by the FDA under a separate petition process. | ![]() buywell3 | |
09/10/2019 08:16 | Lets just remind everyone After 5 years of trying GBP40 million MCap OPTI produced just 147k revenue Burning Cash At the AGM Special Resolution was passed for another possible dilutive placing | hamidahamida | |
09/10/2019 08:14 | I am amazed that Goetz think the Pharma LPLDL is only worth 3p. The milestones almost amount to that value. Should be much higher IMHO. | ![]() nobbygnome | |
09/10/2019 08:13 | Marvellous James - lets hope our seller doesnt decide to take advantage of our good news and ruin our party and any rise. Fingers crossed. Slugs our tgere, blackbird incoming - run. | whitegold1 | |
09/10/2019 08:13 | Marvellous James - lets hope our seller doesnt decide to take advantage of our good news and ruin our party and any rise. Fingers crossed. Slugs our tgere, blackbird incoming - run. | whitegold1 | |
09/10/2019 08:11 | Definitely good news, though as the RNS references the Feb 19 announcement, I had mistakenly thought we had achieved this already. If I am correct this could affect the Goetz valuation. In chart 119, LPldl (pharma) is rated high risk with only 10% probability of success. So this accreditation might bump that probability up a bit. At 10%, Goetz value LPldl (pharma) at 3p out of the total valuation of 97p. Any thoughts on the Goetz note appreciated. MU | ![]() m4rtinu | |
09/10/2019 08:11 | Although everyone is entitled to their views, I don't know why people like Sienna bother posting without backing the reasons for not investing in OPTI. Just invest somewhere else. There is still a way to go, but GRAS is a gold standard for many countries and will allow pharmas to get on board with Phase 3 trials. Good news imo, but it may take some time. I think eventually this will fly. | ![]() 2vdm | |
09/10/2019 08:09 | Isn’t it wonderful to see all the muppets desperately panicking over their short. I love it. | jamesrs1 | |
09/10/2019 08:07 | Cheers Nobby ...Phase 111 ...good. | whitegold1 | |
09/10/2019 08:06 | Google away Buywell. You have zero credibility. Stop trying to sound knowledgable - it it aint working - you.re not while blatantly trying to scare small pi.s you utter slimeball.Hope you.re short spreadbet is hurting today. What an infestation of trolls here. | whitegold1 | |
09/10/2019 08:04 | The important thing about GRAS is the safety so that the Pharma company can go straight to phase III and multiple companies can put the LPLDL in whatever food product they want with absolutely no concern. Massive! | ![]() nobbygnome | |
09/10/2019 08:03 | I see buywell is frantically googling to find anything which possibly could be conceived as negative. Very sad.... | ![]() nobbygnome | |
09/10/2019 08:00 | GRAS In evaluating the safety of the intended use, the FDA considers only safety; benefits are not evaluated, although health claims may be considered by the FDA under a separate petition process. | ![]() buywell3 | |
09/10/2019 08:00 | Good news. What I.m not happy about, and it might be my fault, is that I was totally unaware of this manufacturing additional bit of paper. Is there are similar one reqd for the EU equivalent? These extra reqs clearly stop any potential revenue ( bar the milestone bit) I feel like a shroom - sadly. I.m a loyal holder, occasionally ignorant of wider matters but tiday I feel cheesed but pleased. | whitegold1 | |
09/10/2019 07:58 | Sienna i'd be surprised if purple knows what a probiotic is | ![]() webb93 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions